Interchangability -- It's more than just biosimilars
In case you think the issue of interchangability is only relevant to the biosimilars debate, have a look at this story from the New York Times.
The tort bar is watching -- and salivating.
And patient care is suffering.
Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.